DFSVX | TRSLX | DFSVX / TRSLX | |
Total Expense Ratio | 0.31 | 1.40 | 22% |
Annual Report Gross Expense Ratio | 0.31 | 1.47 | 21% |
Fund Existence | 32 years | 8 years | - |
Gain YTD | -6.462 | -7.186 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.9B | 78.1M | 19,078% |
Annual Yield % from dividends | 1.65 | 0.00 | - |
Returns for 1 year | 1.83 | -17.11 | -11% |
Returns for 3 years | 19.38 | -26.15 | -74% |
Returns for 5 years | 86.94 | -36.23 | -240% |
Returns for 10 years | 30.89 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPSK | 18.10 | -0.07 | -0.39% |
SP Funds Dow Jones Global Sukuk ETF | |||
HEFA | 37.66 | -0.40 | -1.05% |
iShares Currency Hedged MSCI EAFE ETF | |||
ONOF | 33.14 | -0.38 | -1.12% |
Global X Adaptive US Risk Management ETF | |||
EMGF | 51.00 | -0.83 | -1.60% |
iShares Em Mkts Eq Fac ETF | |||
BBC | 19.85 | -0.34 | -1.68% |
Virtus LifeSci Biotech Clinical Trls ETF |